ResMed
RMD
$1.40 (-0.64%)
1D
1W
3M
1Y
5Y
ALL
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
GlobeNewsWire • 2 days ago • RMD
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP TherapyZacks Investment Research • 3 days ago • RMD
What Makes ResMed (RMD) a New Strong Buy StockZacks Investment Research • 3 days ago • RMD
Here is Why Growth Investors Should Buy ResMed (RMD) NowZacks Investment Research • 4 days ago • RMD
Why ResMed (RMD) is a Top Growth Stock for the Long-TermZacks Investment Research • 5 days ago • RMD
4 Top Stocks to Invest in for Astounding Earnings GrowthCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.